GoHealth Shares Jump 2.12% After Oppenheimer Reaffirms Outperform Rating
GHC•Oppenheimer has kept an Outperform rating on GoHealth, prompting a 2.12% share price gain on June 25, 2026. With a market capitalization of about $5.08 billion and a share price near its 52-week high, investor sentiment remains strongly positive.
1. Oppenheimer Maintains Outperform Rating
Oppenheimer has retained its Outperform rating on GoHealth, signaling analysts expect the shares to outperform the market average. The firm advises investors to hold current positions rather than initiating new buys or sells.
2. June 25 Share Price Performance
On June 25, GoHealth shares rose by $24.36, or 2.12%, trading between $1,146.19 and $1,174.99, reflecting a positive response to the reinforced rating.
3. 52-Week Trading Range
Over the past year, share prices oscillated between $882.21 and $1,224.76, placing current levels near the upper end of the 52-week spectrum.
4. Market Capitalization and Trading Volume
GoHealth's market capitalization stands at approximately $5.08 billion, with daily trading volume of about 11,944 shares, indicating moderate liquidity for the session.
